What recommendations are made for the treatment of hypertriglyceridemia in children with CKD?
TLC is recommended for children with CKD and hypertriglyceridemia. Fibric acid derivatives are not recommended to prevent pancreatitis or reduce cardiovascular risk in children with CKD and hypertriglyceridemia. Treatment could be considered in children with very severely increased hypertriglyceridemia (411.3 mmol/l [41000 mg/dl]); such children should be referred to a pediatric lipid specialist for management and to rule out familial hypertriglyceridemia or rare, inherited disorders such as lipoprotein lipase deficiency or apolipoprotein C-II deficiency. Additionally, research is recommended to determine the prevalence of hypertriglyceridemia in pediatric kidney transplant recipients, as well as the effect of diet and weight loss in lowering TG among pediatric CKD patients.